Pioglitazone Inhibits the Expressions of P22(phox) and P47(phox) in Rat Mesangial Cells In Vitro

Overview

Journal ISRN Endocrinol

Specialty Endocrinology

Date 2014 Mar 19

PMID 24639901

Authors

Shan Wang

Shan-Dong Ye

Wen-Jia Sun

Yuan-Yuan Hu

Affiliations

Soon will be listed here.

Abstract

Aim. The purpose of this study was to investigate the effects of pioglitazone on oxidative stress and the expressions of p22(phox) and p47(phox), subunits of NADPH oxidase, in mesangial cells (MCs). Method. Rat mesangial cells were cultured and randomly divided into normal glucose (NG) group, high glucose (HG) group, and pioglitazone group. After 48 h exposure, the supernatants and cells were collected. The expressions of p22(phox) and p47(phox) in MCs were detected by RT-PCR and western blot. The levels of intracellular ROS were determined by flow cytometry. Coloimetry method was used to detect malondialdehyde (MDA) concentrations and superoxide dismutase (SOD) activities. Results. Compared with the NG group, the expression levels of p22(phox), p47(phox) and ROS significantly increased, the activity of SOD decreased in HG group, while the concentration of MDA greatly increased (P < 0.01). Pioglitazone significantly suppressed HG-induced p22(phox) and p47(phox) expressions and oxidative stress. The protein and gene expressions of p22(phox) and p47(phox) were markedly reduced after pioglitazone treatment, so did the ROS generation. The activities of SOD in MCs increased, while the concentrations of MDA in the supernatant decreased greatly by pioglitazone. Conclusions. Pioglitazone can inhibit HG-induced oxidative stress in MCs through suppressing p22(phox) and p47(phox) expressions.

References

Shi D, Wu J, Ge H, Tan R . Protective effect of hopeahainol A, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced injury in PC12 cells. Environ Toxicol Pharmacol. 2011; 28(1):30-6. DOI: 10.1016/j.etap.2009.01.009. View

Kanwar Y, Wada J, Sun L, Xie P, Wallner E, Chen S . Diabetic nephropathy: mechanisms of renal disease progression. Exp Biol Med (Maywood). 2007; 233(1):4-11. DOI: 10.3181/0705-MR-134. View

Kampoli A, Tousoulis D, Pallantza Z, Paterakis G, Papageorgiou N, Oikonomou E . Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus. Int J Cardiol. 2012; 157(3):413-5. DOI: 10.1016/j.ijcard.2012.03.159. View

Campos C . Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med. 2013; 124(6):90-7. DOI: 10.3810/pgm.2012.11.2615. View

Hu Y, Ye S, Zhao L, Zheng M, Wu F, Chen Y . Hydrochloride pioglitazone decreases urinary cytokines excretion in type 2 diabetes. Clin Endocrinol (Oxf). 2010; 73(6):739-43. DOI: 10.1111/j.1365-2265.2010.03878.x. View

Wang X, Wang Z, Liu J, Hu J, Chen H, Li W . Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Toxicol In Vitro. 2011; 25(4):839-47. DOI: 10.1016/j.tiv.2011.02.004. View

Mokini Z, Marcovecchio M, Chiarelli F . Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways. Diabetes Res Clin Pract. 2009; 87(3):313-21. DOI: 10.1016/j.diabres.2009.11.018. View

Singh D, Winocour P, Farrington K . Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol. 2010; 7(3):176-84. DOI: 10.1038/nrendo.2010.212. View

Inoguchi T . [Role of oxidative stress in pathogenesis of diabetic nephropathy]. Nihon Jinzo Gakkai Shi. 2011; 53(7):1016-20. View

10.

Yang H, Deleuze S, Zuo Y, Potthoff S, Ma L, Fogo A . The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol. 2009; 20(11):2380-8. PMC: 2799181. DOI: 10.1681/ASN.2008111138. View

11.

Chen J, Stinnett A . Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Invest. 2008; 88(12):1316-28. DOI: 10.1038/labinvest.2008.92. View

12.

Lee I, Shih R, Lin C, Chen J, Yang C . Role of TLR4/NADPH oxidase/ROS-activated p38 MAPK in VCAM-1 expression induced by lipopolysaccharide in human renal mesangial cells. Cell Commun Signal. 2012; 10(1):33. PMC: 3509033. DOI: 10.1186/1478-811X-10-33. View

13.

Deepa D, Jayakumari N, Thomas S . Oxidative stress is increased in women with epilepsy: Is it a potential mechanism of anti-epileptic drug-induced teratogenesis?. Ann Indian Acad Neurol. 2013; 15(4):281-6. PMC: 3548366. DOI: 10.4103/0972-2327.104336. View

14.

Jesse C, Bortolatto C, Wilhelm E, Roman S, Prigol M, Nogueira C . The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice. J Appl Toxicol. 2012; 34(1):25-32. DOI: 10.1002/jat.2818. View

15.

Toblli J, Ferrini M, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid N . Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol Dial Transplant. 2009; 24(8):2384-91. PMC: 2727296. DOI: 10.1093/ndt/gfp103. View

16.

Qian Y, Feldman E, Pennathur S, Kretzler M, Brosius 3rd F . From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 2008; 57(6):1439-45. PMC: 4239998. DOI: 10.2337/db08-0061. View

17.

Kong X, Zhang Y, Wu H, Li F, Zhang D, Su Q . Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake. Oxid Med Cell Longev. 2012; 2012:856085. PMC: 3505666. DOI: 10.1155/2012/856085. View

18.

Jiang F, Zhang Y, Dusting G . NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev. 2011; 63(1):218-42. DOI: 10.1124/pr.110.002980. View

19.

Masoad R, Ewais M, Tawfik M, Abd El-All H . Effect of mononuclear cells versus pioglitazone on streptozotocin-induced diabetic nephropathy in rats. Pharmacol Rep. 2012; 64(5):1223-33. DOI: 10.1016/s1734-1140(12)70918-0. View

20.

Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A . The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 2011; 7(5):313-24. DOI: 10.2174/157339911797415585. View